Cobo Marc

Principal Accounting Officer

Cobo Marc has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Nov 17, 2026.

On the most recent filing, Cobo Marc is listed as Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. Inside the rolling window, Cobo Marc reported no open-market purchases and 1 open-market sale totaling $185 in BBOT.

Companies traded

Other insiders at BBOT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$185

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BBOTSale$185Nov 17SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Cobo Marc made?

Cobo Marc has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.

Which companies does Cobo Marc trade?

Cobo Marc has filed SEC Form 4 disclosures for 1 company, including BBOT.

When was Cobo Marc's most recent SEC Form 4 filing?

Cobo Marc's most recent SEC Form 4 filing on Tracefour is dated Nov 17, 2026.

What is Cobo Marc's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Cobo Marc is listed as Principal Accounting Officer.

What is Cobo Marc's total buy and sell value in the current window?

Inside the rolling retention window, Cobo Marc bought $0 and sold $185 based on SEC Form 4 filings.

What was Cobo Marc's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 78 BBOT shares on 2026-11-13, worth $185, per SEC Form 4 filings.